Datavault AI and Wellgistics Health to Integrate Blockchain Technology for Pharmaceutical Distribution

Datavault AI and Wellgistics Health Inc. have signed a non-binding letter of intent to integrate DataVault's blockchain-enabled PharmacyChain smart contract technology into Wellgistics' proprietary infrastructure. This collaboration focuses on digitizing prescription tracking from script to fulfillment, ensuring accurate, transparent and efficient delivery while supporting patient safety and optimized outcomes. The integration represents a significant step toward modernizing pharmaceutical distribution through advanced technology solutions.

The companies are exploring a revenue-sharing model based on PharmacyChain usage fees, with definitive terms to be determined following further negotiation. This potential financial arrangement demonstrates the commercial viability of blockchain applications in healthcare logistics. The technology aims to create an immutable record of prescription transactions, reducing errors and improving accountability throughout the medication distribution process. This approach could set new standards for transparency in pharmaceutical supply chains.

Datavault AI's technology suite offers comprehensive solutions serving multiple industries, including healthcare, through its cloud-based platform. The company leverages Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation and secure monetization. Their Information Data Exchange enables Digital Twins and licensing of name, image, and likeness by securely attaching physical real-world objects to immutable metadata objects. More information about Datavault AI's technology can be found at https://www.datavaultsite.com.

The forward-looking statements in this announcement are subject to various risks and uncertainties, including factors beyond management's control. These risks are detailed in the company's most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q filed with the SEC. The full terms of use and disclaimers applicable to this content are available at http://IBN.fm/Disclaimer. The companies undertake no duty to update this information unless required by law.